Item | Effective group (EG) | Less effective group (LG) |
---|---|---|
Number of patients | 12 | 10 |
Age (mean ± SD) at onset | 87.9 ± 9.0 | 85.5 ± 7.3 |
  range | 71.0-101.0 | 73.0-98.0 |
Gender (male/female) | 4/8 | 8/2 |
Admission diagnosis | Â | Â |
  PU | 8 | 7 |
  Tumor | 0 | 1 |
  Pneumonia | 4 | 0 |
  COPD | 0 | 1 |
  CIS | 0 | 1 |
Hospitalized days (mean ± SD) | 113.3 ± 89.6 | 155.4 ± 92.6 |
  range | 32-379 | 63-335 |
DESIGN-Rating (mean ± SD) at onset | 14.0 ± 5.4 | 12.7 ± 3.3 |
Wound size (mean ± SD) at onset | 6.9 ± 0.9 cm2 | 6.3 ± 0.9 cm2 |
Locations* | Â | Â |
  Total | 16 | 12 |
  Back | 3 | 0 |
  Sacrum | 3 | 5 |
  Buttocks | 3 | 2 |
  Ilium | 1 | 3 |
  Greater trochanter | 2 | 1 |
  Thigh | 1 | 0 |
  Knee | 1 | 0 |
  Heel | 1 | 1 |
  Toes | 1 | 0 |
Stages at onset (number of locations*) | Â | Â |
  Stage II | 6 | 4 |
  Stage III | 10 | 8 |